Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;26(1):100-6.
doi: 10.1016/j.drugpo.2014.06.013. Epub 2014 Jun 24.

Perceptions of genetic testing and genomic medicine among drug users

David C Perlman  1 , Camila Gelpí-Acosta  2 , Samuel R Friedman  2 , Ashly E Jordan  3 , Holly Hagan  3
Affiliations

Perceptions of genetic testing and genomic medicine among drug users

David C Perlman et al. Int J Drug Policy. 2015 Jan.

Abstract

Background: Genetic testing will soon enter care for human immunodeficiency virus (HIV) and hepatitis C virus (HCV), and for addiction. There is a paucity of data on how to disseminate genetic testing into healthcare for marginalized populations. We explored drug users' perceptions of genetic testing.

Methods: Six focus groups were conducted with 34 drug users recruited from syringe exchange programmes and an HIV clinic between May and June 2012. Individual interviews were conducted with participants reporting previous genetic testing.

Results: All participants expressed acceptance of genetic testing to improve care, but most had concerns regarding confidentiality and implications for law enforcement. Most expressed more comfort with genetic testing based on individual considerations rather than testing based on race/ethnicity. Participants expressed comfort with genetic testing in medical care rather than drug treatment settings and when specifically asked permission, with peer support, and given a clear rationale.

Conclusion: Although participants understood the potential value of genetic testing, concerns regarding breaches in confidentiality and discrimination may reduce testing willingness. Safeguards against these risks, peer support, and testing in medical settings based on individual factors and with clear rationales provided may be critical in efforts to promote acceptance of genetic testing among drug users.

Keywords: Drug users; Genetic testing; HCV; HIV; Perceptions; Racial/ethnic minorities.

PubMed Disclaimer

References

    1. Moonesinghe R, Jones W, Honore PA, Truman BI, Graham G. Genomic medicine and racial/ethnic health disparities: Promises, perils, and the challenges for health care and public health policy. Ethnicity & disease. 2009;19:473–478. - PubMed
    1. Gerretsen P, Muller DJ, Tiwari A, Mamo D, Pollock BG. The intersection of pharmacology, imaging, and genetics in the development of personalized medicine. Dialogues in clinical neuroscience. 2009;11:363–376. - PMC - PubMed
    1. Downing GJ. Policy perspectives on the emerging pathways of personalized medicine. Dialogues in clinical neuroscience. 2009;11:377–387. - PMC - PubMed
    1. Hutchison KE. Substance use disorders: Realizing the promise of pharmacogenomics and personalized medicine. Annual review of clinical psychology. 2010;6:577–589. - PubMed
    1. Kulkarni H, Marconi VC, Agan BK, McArthur C, Crawford G, Clark RA, Dolan MJ, Ahuja SK. Role of ccl3l1-ccr5 genotypes in the epidemic spread of hiv-1 and evaluation of vaccine efficacy. PLoS One. 2008;3:e3671. - PMC - PubMed

Publication types